A quarter of a century after AIDS became known as a frightening new disease, substantial progress has been attained on treatments that convert this once certain death sentence into a manageable chronic disease.
Under various completed or ongoing projects, rapid progress has been attained in the generation of genomic resources for model organisms and domestic animals of medical, economic, or agricultural importance (e.g. [ 1- 3]).
Less progress has been made in combating the "too-big-to-fail" problem.
However, slightly less progress has been made socially.
Less progress has been made on two other issues inherited from the Haass talks.
Our data show that while some progress has been made on some barriers, less progress has been made on others.
Although both are clinically relevant, less progress has been made in the field of the latter.
In terms of achieving sharing of participant-level data sets, less progress has been made.
Considerably less progress has been made in the development of precision medicine strategies for BRAF-wild-type melanoma.
Less progress has been made in the management of rectal cancer.
